My bookmarksSign up free
Source

Commission Implementing Decision (EU) 2021/1895 of 28 October 2021 establishing the equivalence, for the purpose of facilitating the right of free movement within the Union, of COVID-19 certificates issued by the United Kingdom of Great Britain and Northern Ireland to the certificates issued in accordance with Regulation (EU) 2021/953 of the European Parliament and of the Council (Text with EEA relevance)

Commission Implementing Decision (EU) 2021/1895 of 28 October 2021 establishing the equivalence, for the purpose of facilitating the right of free movement within the Union, of COVID-19 certificates issued by the United Kingdom of Great Britain and Northern Ireland to the certificates issued in accordance with Regulation (EU) 2021/953 of the European Parliament and of the Council (Text with EEA relevance)

Implementing Decision (EU) 2021/1895 · Decision · 3 articles

Data as of 2026-07-04 · Compiled from an official source version. Later amendments or repeals may not be reflected; the official text prevails. · Read the official text ↗

Article 1

Open ↗

COVID-19 vaccination, test and recovery certificates issued by the United Kingdom of Great Britain and Northern Ireland in accordance with the system entitled “UK COVID Certificates” shall, for the purpose of facilitating the right of free movement within the Union, be considered as equivalent to those issued in accordance with Regulation (EU) 2021/953.

Article 2

Open ↗

The United Kingdom of Great Britain and Northern Ireland shall be connected to the EU Digital COVID Certificate trust framework established by Regulation (EU) 2021/953.

Article 3

Open ↗

This Decision shall enter into force on the day of its publication in the Official Journal of the European Union .

Other acts of the same type
Commission Implementing Decision (EU) 2025/1097 of 23 May 2025 amending the Annex to Implementing Decision (EU) 2025/672 concerning certain emergency measures relating to outbreaks of foot and mouth disease in Hungary and Slovakia (notified under document C(2025) 3463)Commission Implementing Decision (EU) 2025/1100 of 23 May 2025 adopting guidelines for the implementation of certain selection criteria for net-zero strategic projects laid down in Article 13 of Regulation (EU) 2024/1735 of the European Parliament and of the CouncilCouncil Implementing Decision (EU) of 22 May 2025 on the appointment of four full-time members of the Executive Board of the Authority for Anti-Money Laundering and Countering the Financing of TerrorismCouncil Decision of 22 May 2025 replacing a member of the Management Board of the European Centre for the Development of Vocational Training (Cedefop) for DenmarkCouncil Decision of 22 May 2025 amending Decision (EU) 2023/133 as regards the replacement of a member of the selection panel provided for in Article 14(3) of Regulation (EU) 2017/1939Commission Implementing Decision (EU) 2025/944 of 22 May 2025 postponing the expiry date of the approval of DDACarbonate for use in biocidal products of product-type 8 in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the CouncilCommission Implementing Decision (EU) 2025/945 of 22 May 2025 postponing the expiry date of the approval of nonanoic acid for use in biocidal products of product-type 2 in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the CouncilCommission Implementing Decision (EU) 2025/946 of 22 May 2025 postponing the expiry date of the approval of octanoic acid for use in biocidal products of product-type 4 in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the CouncilCommission Implementing Decision (EU) 2025/947 of 22 May 2025 postponing the expiry date of the approval of iodine for use in biocidal products of product-type 3 in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the CouncilCommission Implementing Decision (EU) 2025/949 of 22 May 2025 postponing the expiry date of the approval of decanoic acid for use in biocidal products of product-type 4 in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the CouncilCommission Implementing Decision (EU) 2025/950 of 22 May 2025 postponing the expiry date of the approval of 1R-trans phenothrin for use in biocidal products of product-type 18 in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the CouncilCommission Implementing Decision (EU) 2025/951 of 22 May 2025 postponing the expiry date of the approval of polyvinylpyrrolidone iodine for use in biocidal products of product-types 1 and 3 in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council

Source: EUR-Lex (Publications Office of the EU), © European Union, reuse permitted under Commission Decision 2011/833/EU.

Contents

What to look at next